MATERIALS AND METHODS
Adult male and female Sprague-Dawley rats were obtained from Charles River Labs and were bred according to the procedure described previously (7). At least three pregnant rats each on embryonic days E12, E13, E14, E15, or El6 were injected with approximately 7 uCi/gm body weight of [$]thymidine (1 mCi/ml, specific activity 6.7 Ci/mmol) (New England Nuclear). The male progeny were collected for the experiment. Three or more adult males from each injection group (i.e., embryonic days E12-E16) were injected ICV with 50-200 ug/lOul colchicine 24-48 hours prior to sacrifice. Animals were anesthetized and perfused with 4% formaldehyde, and the brains were processed for peroxidase-antiperoxidase immunocytochemistry as described before (8). Primary rabbit antisera used were raised against ACTH (to localize proopiomelanocortin neurons in the arcuate nucleus), dynorphin A (magnocellular supraoptic nucleus) and [Leulenkephalin (periventricular nucleus). After th completion of immunocytochemistry, the sections were processed for [?l]thymidine autoradiography (see 9). After development and fixation, the sections were dehydrated through ethanols and xylenes and coverslipped. With the aid of a microscope, immunoreactive perikarya belonging to each specific peptide group, and with an identifiable nucleus, were counted in several sections. The cell nuclei were designated as heavy/medium labelled (H/M) or light/un-labelled (L/U) depending on the density of autoradiographic grains (Fig. 1) . The results for each peptide group on each embryonic day were expressed as the percent H/M over the total number of immunoreactive perikarya (i.e., H/M : (H/M + L/U) x 100). "Blind" counts were made by independent observers to reduce experimental bias. Analysis of variance was performed for each neuronal population. 
RESULTS
The ACTH-containing perikarya in the arcuate nucleus showed heavy nuclear-labelling patterns at early embryonic stages s udied. On days El2 and SH El3 alone over 50% of immunoreactive cells exhibited [ lthymidine labelling. The labelling patterns declined gradually from El4 through El6 (only 2% of cells on the last day). The dynorphin A-contain ng magnocellular perikarya of the supraoptic nucleus exhibited peak heavy [ f Ithymidine labelling on day E13. Nevertheless, a major proportion (over 80%) of dynorphin A cells were "born" prior to E15, with only a minor population being labelled heavily on days El5 
DISCUSSION
Some of the observed patterns of neurogenesis in the present study correspond well with previous developmental studies, while others do not. The present finding of the early origin of AClE-containing neurons in the arcuate nucleus (29% at E12) corresponds well with immunocytochemical localization of ACTH and other proopiomelanocortin products in arcuate neurons as early as day El2 (2,4). On the other hand, the finding of peak labelling of supraoptic dynorphin A neurons on day E13, as well as peak labelling of periventricular [Leulenkephalin neurons on day E14, does not agree with the observed immunoreactivity in developing embryos during late gestation, e.g., E17-El8 (3,4). Based on these observations, there appears to be no time lag between the onset of neurogenesis of arcuate proopiomelanocortin neurons and the initation of peptide synthesis. Conversely, a time lag of several days seems to exist between the onset of neuron differentiation and dynorphin A or [Leulenkephalin synthesis. One simple explanation may be that the antisera used for the detection of the latter peptides in developmental immunocytochemical studies are not as sensitive as the anti-ACTS serum or that these peptides exist mainly in precursor form and/or in minute quantities during early gestation. Thus, the low quantities or precursor "masking" might render (i.e., the latter peptides undetectable at such early gestational stages E13-E14). Alternatively, these supraoptic and periventricular neurons might not begin synthesis of their respective opioid products until several days after they are born, or might express nonopioid products earlier (e.g., vasopressin in the case of supraoptic neurons).
Another interesting observation in the present study is that the patterns of neurogenesis of opioid peptide-containing neurons in any given region of the hypothalamus do in that region as a the latest arising according to Altman not necessarily correspond to the patterns of cell birth whole (see 5). For example, the arcuate nucleus is among of nuclei in the hypothalamus (over 60% at E14-El6 and Bayer, 61, while the ACTS cells which make up a minor 
